Trajectories of entering the metabolic syndrome: the framingham heart study

Oscar H Franco1, Joseph M Massaro, Jacky Civil

  • 1Unilever Corporate Research, Sharnbrook, UK. O.H.Franco@warwick.ac.uk

Circulation
|November 4, 2009
PubMed
Summary

Individuals developing metabolic syndrome (MetS) with specific risk factor combinations face higher cardiovascular disease and mortality risks. Early identification and treatment of these high-risk groups are crucial for better outcomes.